Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0042963 (vomiting)
 31,883 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A group of 71 women between 11-20 weeks of gestation who desired termination of pregnancy and had no contraindications for prostaglandin (PG) administration were given complete physical and gynecological examinations; hemoglobin was estimated and urinalysis was done. They were then given orally 2 tablets of Lomotil (diphenoxylate HCl 2.5 mg + atropine sulphate 0.025 mg) and 1 tablet of Stemetil (Prochlorperazine 5 mg). They were then given 15 (S) 15 methyl PGF2alpha intravenously at the dose level of 1 mcg/min. 61 subjects (85.9%) aborted within 30 hours. At regular intervals pulse rate, blood pressure, uterine pain, nausea, vomiting, diarrhea, temperature, and respiratory rate were measured and any other side effects were recorded. The mean induction abortion interval was 15.65 hours, the mean number of episodes of vomiting and diarrhea was 0.9 and 0.6 respectively. This study compared well with the intramuscular route of administration with a higher rate of complete abortions and lower rate of side effects. The latter is explained on the basis of smaller amounts of the drug being infused at a slower rate. Disadvantages include confinement to bed, discomfort, and need of constant supervision. Compared with intraamniotic and extraamniotic case studies, the latter are invasive procedures while the intravenous method is not. Also, the intravenous route allows for adjusted drug dosage and stopping the procedure in the event of an undesirable reaction.
 ...
PMID:Midtrimester abortion with intravenous administration of 15 methyl prostaglandin F2 alpha. 612 31

We describe the case of a 10-year-old boy who had been admitted on several occasions with a diagnosis of gastroenteritis. He had been severely ill, and on one occasion lost consciousness. He had a metabolic acidosis on these occasions. Examination of the urine by gas chromatography-mass spectrometry showed a large peak, identified as glycerol. The concentration of glycerol in the urine was 40-280 mmol/L and the concentration in plasma about 2 mmol/L. He was subjected to a fast of 21 h, at the end of which he expressed feelings of discomfort and nausea, began vomiting, and became somnolent. During this period the blood glucose concentration was only slightly decreased, the plasma glycerol concentration increased to 4.9 mmol/L, and the plasma lactate concentration increased to 3.8 mmol/L. During work on a bicycle ergometer for 35 min (40 W) he complained of muscle pain and became nauseated, but there was no significant increase in the concentration of plasma glycerol. The activity of glycerol kinase (EC 2.7.1.30) in leukocytes and cultured fibroblasts was less than 1% of the value for healthy subjects.
 ...
PMID:Deficiency of glycerol kinase (EC 2.7.1.30). 629 16

In cytostatic drug treatment, nausea and vomiting are very frequent, unpleasant and undesirable side effects that cause considerable discomfort to the patient. However, many established antiemetics (Torecan, haloperidol, Valium, Largactil etc.) have not shown significant antiemetic activity in the patients to whom cytostatics were applied. In our controlled randomized clinical trial, the antiemetic activity of methylprednisolone was investigated and compared with placebo (10 ml saline) and Torecan. All the compounds were injected before cis-platinum administration, knowing that this agent induces vomiting in almost 100% of patients. Ninety patients entered the study and have been evaluated. The results of the trial have shown that methylprednisolone in the single dose of 250 mg applied i.v. 2 h before injection of a cytostatic agent experienced pronounced antiemetic activity in 48% of the patients (15/31), as compared to Torecan 21% (6/29) and placebo 13% (4/30). This difference was statistically significant (P less than 0.01). No side effects were recorded after methylprednisolone application. The results of the study showed that methylprednisolone possesses a pronounced antiemetic activity in almost half of the patients treated with cis-platinum.
 ...
PMID:Methylprednisolone as an antiemetic in patients on cis-platinum chemotherapy. Results of a controlled randomized study. 634 Mar

We compared Hexabrix 320 (580 mOsm kg-1) with Conray 420 (2500 mOsm kg-1) for left ventriculography using a prospective randomised double-blind protocol. One hundred consecutive patients with suspected coronary disease were assigned to Hexabrix (52) or Conray (48) for left ventriculography (dose 10 ml m-2 BSA; flow rate 12 ml s-1). Thirteen patients found Hexabrix unpleasant compared with 24 receiving Conray; overall the feelings of warmth and discomfort were less with Hexabrix than Conray (p less than 0.01 and p less than 0.02 respectively). The incidence of nausea, vomiting, and hypersensitivity was similar. Angiographic quality was better with Conray than with Hexabrix (p less than 0.05). Average changes in heart rate and systolic pressure were similar, though there was greater variation in systolic pressure change after Conray (p less than 0.025). End diastolic pressure increased more after Conray than after Hexabrix (p less than 0.05). These slight advantages of Hexabrix over Conray may be valuable in patients requiring multiple angiograms or in those with impaired cardiac function, but do not justify its use for routine angiography.
 ...
PMID:Comparison of Hexabrix 320 and Conray 420 for left ventriculography in patients with coronary artery disease. 636 33

Despite some evidence that gastric decompression may be unnecessary after some abdominal operations and in the treatment of paralytic ileus, the use of nasogastric suction after extensive abdominal operations, particularly intestinal resection, remains a subject of some debate. In a randomized prospective trial, 52 patients with suture lines constructed in the gastrointestinal tract received no postoperative nasogastric drainage unless acute gastric dilation or copious vomiting developed postoperatively, while 45 similar patients were allocated to receive routine postoperative nasogastric aspiration. Only 12 patients in the nonintubated group required subsequent insertion of a nasogastric tube, while in the remaining 40, nasogastric drainage was avoided completely. Postoperative loss of fluid from the intestine was significantly greater in the patients undergoing routine nasogastric drainage, although the requirement for intravenous fluid therapy was the same in both groups. There were no significant differences between the two groups in the incidence of postoperative complications. Routine nasogastric aspiration after gastric or intestinal resection does not confer significant advantages to outweigh its discomfort and potential morbidity for patients and should be replaced by selective intubation when required postoperatively.
 ...
PMID:Nasogastric intubation after intestinal resection. 636 83

Ceftazidime (CAZ), a new cephalosporin antibiotic, was studied in the field of obstetrics and gynecology, and the following results were obtained. The absorption and tissue penetration of CAZ into intrapelvic genital organs were good after a single drip infusion of 1.0 g for 30--60 minutes. The maximum level of 76.4 micrograms/ml was obtained in uterine artery serum at 8 minutes after administration. The high concentrations were also obtained in genital tissues; the maximum concentrations ranged from 46.8--62.1 micrograms/g at 20 minutes after administration and the levels were as high as 2.1--7.7 micrograms/g at 5 hours and 40 minutes after administration. The concentration curves in tissues were consistent with those of serum levels. The concentrations of CAZ in retroperitoneal dead space exudate were determined after intravenous drip infusion of 1 g. The peak levels ranged from 26 to 32 micrograms/ml after 30 minutes of administration and the level of 8.53 micrograms/ml was sustained even 6 hours later. Good response was obtained in cases of gyneco-obstetric infections such as intrauterine infection, intrapelvic infection and external genital infection with daily dose of 2--4 g. CAZ was effective in 13 out of 14 cases (the efficacy ratio; 92.9%). As to side effects, gastric discomfort and vomiting were observed in 1 case.
 ...
PMID:[Basic and clinical studies on ceftazidime in the field of obstetrics and gynecology]. 637 Dec 94

In the etiology of premature labor prostaglandins fulfill a significant role. It is known that indomethacin is a strong inhibitor of prostaglandin synthesis. The effect of indomethacin on premature labor was studied in a prospective randomized double-blind study in 36 patients. Eighteen patients received indomethacin and eighteen received placebo. 200-300 mg of indomethacin was the total dosage in a 24 hours period. The activity of the uterus was monitored with a cardiotocograph. The mean duration of pregnancy and the mean birth weight in indomethacin group (36.4 weeks, 2833 g) were both significantly greater (p less than 0.001) than that in placebo group (31.2 weeks, 2028 g). In the indomethacin group 3 children weighted less than 2500 g compared with 14 in placebo group. In 15 of 18 indomethacin treated patients (83.3%) premature labor was arrested after indomethacin treatment compared with 4 of 18 in the placebo group (22.2%). The indomethacin group had a mean 1 minute APGAR score of 9.3 +/- 0.2 whereas the placebo group showed a score of 7.8 +/- 0.5 (p less than 0.01). Three infants died from respiratory distress syndrome; one in the indomethacin group (1810 g) and two in the placebo group (600 and 1450 g). Autopsies in the infants demonstrated a typical picture of pulmonary atelectasis and hyaline membranes. There was no evidence of premature closure of the ductus arteriosus or pulmonary hypertension. 2 mothers in the indomethacin group suffered minor discomfort i.e. nausea, vomiting and vertigo.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Further study of the inhibition of premature labor by indomethacin. Part II double-blind study. 637 98

In a double-blind randomized assignment of Renografin-76 or Hexabrix, 65 patients were evaluated to determine the safety and efficacy of Hexabrix, and to assess subtle differences and their implications in image quality. Dosage was adjusted for patient weight, and up to 150-ml of Hexabrix or Renografin-76 were injected over a 2-minute period during which rapid sequence CT was performed. Less heat and discomfort were noted with Hexabrix. No difference was evidenced in the side effects of emesis or hives, and no real difference in renal dysfunction was noted from a clinical standpoint. Image quality was generally equivalent, with possibly better renal concentration achieved with Hexabrix.
 ...
PMID:Double-blind comparison of Hexabrix and Renografin-76 in computed tomography. 639 68

Data from 34 patients were included in the analysis of this open group comparative study comparing a controlled release theophylline given twice daily with immediate release aminophylline given four times daily. The treatment period was of eight weeks duration. There was no significant difference between treatments in clinical assessments of asthma severity or pulmonary function tests. Similarly there were no significant differences between treatments in diary card assessments of asthma symptoms or PERF. Serum theophylline levels were measured prior to the morning dose of test treatment and 2 or 5 hours later, respectively for patients taking immediate release (IR) or controlled release (CR) preparations, at each clinic visit. There was no significant difference between treatments in serum theophylline levels fluctuations, although the dosing interval (12 hours) was twice as long for CR formulation. Six patients reported unusual symptoms, two in the CR group (headache, gastric discomfort) four in the aminophylline group (three headache, one headache and vomiting).
 ...
PMID:[Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation]. 653 26

The prostaglandins F2alpha (PGF2alpha) and E2 (PGE2) used for abortion during the 2nd trimester of pregnancy were compared and are presented along with a method of management that minimizes patient discomfort. The study included 23 consecutive patients who wanted to undergo elective 2nd trimester abortion at the Unviersity of California, Davis Medical Center, during the January 1981-May 1981 period. Gestational age was determined by menstrual history, fundal size, and, when necessary, ultrasonography. Patients between 14-20 weeks of estimated gestational age were assigned to either PGF2alpha or PGE2 therapy using a set of random numbers. Patients were excluded from the study if a history of significant renal, cardiac, or pulmonary disease was obtained, if a uterine or cervical anomaly was suspected, or if abortion was desired because of a known fetal anomaly, abnormal karyotype, or fetal demise. 13 patients were in the PGF2alpha group and 12 were in the PGE2 group. 4 patients in the PGF2alpha group and 5 in the PGE2 group were nulliparas. The mean induction to abortion interval was 9.19 +or- 6.18 hours, 3-22 hours, for those in the PGF2alpha group and 9.19 +or- 2.59 hours, 5.75-12.78 hours, for those in the PGE2 group. The difference was not statistically significant. The cumulative abortions rates of the 2 methods were similar. Except for 2 patients who received PGF2alpha, all of the patients studied aborted within 14 hours. There was a 31% incidence of emesis in those patients in the PGF2alpha group, but none of these patients had more than a single episode. A 20% incidence of emesis was noted for the PGE2 group, with each of these patients having 2 episodes. No patient had diarrhea or hyperthermia develop, and none required antidiarrheal or antipyretic medication after the intial prophylactic dosages. Of the patients in the PGF2alpha group, 61.5% required supplementary analgesia as compared with 60% for those in the PGE2 group. Of those patients requiring additional analgesia, those in the PGF2alpha group, on an average, had more medication given orally and intramuscularly. Curettage was considered to be an integral part of the abortion procedure. Products of conception were obtained from all of the patients at the time of curettage. No patient returned after discharge from the hospital because of hemorrhage or infection as a result of retained products of conception. With the use of laminaria tents for cervical priming, prophylaxis of minor side effects, oxytocin supplementation and postabortal curettage, PGF2alpha and PGE2 are equivalent midtrimester abortifacients when rapidity, safety, and patient comfort are considered.
 ...
PMID:A comparative study of two types of prostaglandins for abortion during the second trimester. 657 7


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>